Table 4.
Age group specific distribution of chronic hepatitis B in Turkey by HBeAg and stage of liver disease
| Age group | Active CHB | Cirrhosis | Chronic hepatitis (no cirrhosis) |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (years) | Population | HBsAg+ (%) | HBeAg+ | HBeAg− | HBeAg+ | HBeAg− | HBeAg+ (%) | HBeAg− (%) | HBeAg+ | HBeAg− |
| 0–14 | 18,788,587 | 533,596 (2.84) | 283,828 | 249,768 | 90,621 | 47,586 | 1,818 (2) | 2,379 (5) | 88,808 | 45,207 |
| 15–24 | 12,441,662 | 490,201 (3.94) | 176,473 | 313,729 | 91,504 | 45,804 | 1,830 (2) | 2,290 (5) | 89,674 | 43,514 |
| 25–34 | 12,328,944 | 784,121 (6.36) | 159,961 | 624,160 | 113,892 | 132,322 | 6,834 (6) | 9,263 (7) | 107,058 | 123,059 |
| 35–44 | 10,070,734 | 624,386 (6.20) | 62,439 | 561,947 | 35,222 | 96,610 | 2,466 (7) | 14,491 (15) | 32,756 | 82,118 |
| 45–54 | 7,927,348 | 437,590 (5.52) | 22,655 | 414,935 | 11,923 | 74,353 | 2,981 (25) | 20,819 (28) | 8,943 | 53,534 |
| 55–64 | 5,066,402 | 184,924 (3.65) | 12,753 | 172,170 | 5,070 | 41,595 | 1,673 (33) | 21,214 (51) | 3,397 | 20,382 |
| 65+ | 4,893,423 | 197,205 (4.03) | 18,260 | 178,945 | 4,565 | 37,280 | 0 | 20,877 (56) | 4,565 | 16,403 |
| Total | 71,517,100 | 3,252,022 (4.57) | 736,367 | 2,515,655 | 352,797 | 475,550 | 17,595 (9) | 91,333 (19) | 335,202 | 384,217 |
CHB chronic hepatitis B, HBeAg hepatitis B e antigen, HBsAg hepatitis B surface antigen